Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:chemicalFormula |
C47H72O14
|
| gptkbp:hasFilm |
Diarrhea
Dizziness Nausea |
| gptkbp:hasProductLine |
Fermentation
|
| gptkbp:hasWeight |
875.1 g/mol
|
| https://www.w3.org/2000/01/rdf-schema#label |
Avermectin B1b
|
| gptkbp:isAttendedBy |
gptkb:FDA
Oral tablet Multiple doses Single dose |
| gptkbp:isAvailableIn |
Over-the-counter medication
Prescription medication |
| gptkbp:isChallengedBy |
Liver
|
| gptkbp:isConsidered |
Broad-spectrum antiparasitic agent
Cost-effective treatment Effective in low doses Safe for use in adults |
| gptkbp:isDescribedAs |
Water
|
| gptkbp:isEngagedIn |
1970s
|
| gptkbp:isEvaluatedBy |
Bacteria
Viruses Nematodes Ectoparasites |
| gptkbp:isExemplifiedBy |
Bile
|
| gptkbp:isPartOf |
Combination therapies
Antiparasitic drugs WHO Essential Medicines List Avermectin_family |
| gptkbp:isRecognizedFor |
Pregnant women
Nursing mothers Children under 5 years old |
| gptkbp:isRelatedTo |
Ivermectin
|
| gptkbp:isStudiedIn |
gptkb:Ethanol
Cancer treatment Autoimmune diseases Neurological disorders DMSO Inflammatory diseases |
| gptkbp:isSubjectTo |
Room temperature
|
| gptkbp:isUsedBy |
Onchocerciasis
Strongyloidiasis Lice Filariasis Scabies |
| gptkbp:isUsedFor |
Parasitic infections
|
| gptkbp:isUsedIn |
Veterinary medicine
Human medicine |
| gptkbp:isValuedFor |
Streptomyces avermitilis
|